Sharing clinical trial data on patient level: Opportunities and challenges
Sharing clinical trial data on patient level: Opportunities and challenges
In recent months one of the most controversially discussed topics among regulatory agencies, the pharmaceutical industry, journal editors, and academia has been the sharing of patient‐level clinical trial data. Several projects have been started such as the European Medicines Agency´s (EMA) “proactive publication of clinical trial data”, the BMJ open …